E-LIB Suche - Ergebnisse für: Flygt, Hjalmar

1

Treatment-free remission after a second TKI discontinuation..:

Flygt, Hjalmar ; Söderlund, Stina ; Richter, Johan...
Leukemia. 38 (2024) 4 - p. 781-787 , 2024

Link: https://doi.org/10.1038/..

2

Correction: Treatment-free remission after a second TKI dis..:

Flygt, Hjalmar ; Söderlund, Stina ; Richter, Johan...
Leukemia. 38 (2024) 4 - p. 925-925 , 2024

Link: https://doi.org/10.1038/..

3

The impact of Covid-19 in patients with chronic myeloid leu..:

Dahlén, Torsten ; Flygt, Hjalmar ; Lübking, Anna...
Leukemia. 37 (2023) 5 - p. 1156-1159 , 2023

Link: https://doi.org/10.1038/..

4

Adverse outcomes in chronic myeloid leukemia patients treat..:

Dahlén, Torsten ; Edgren, Gustaf ; Ljungman, Per...
American Journal of Hematology. 97 (2022) 4 - p. 421-430 , 2022

Link: https://doi.org/10.1002/..

5

Long‐term tolerability and efficacy after initial PegIFN‐α ..:

Flygt, Hjalmar ; Söderlund, Stina ; Stentoft, Jesper...
European Journal of Haematology. 107 (2021) 6 - p. 617-623 , 2021

Link: https://doi.org/10.1111/..

6

Successful tyrosine kinase inhibitor discontinuation outsid..:

Flygt, Hjalmar ; Sandin, Fredrik ; Dahlén, Torsten...
British Journal of Haematology. 193 (2021) 5 - p. 915-921 , 2021

Link: https://doi.org/10.1111/..

7

Neurosurgical untethering with or without syrinx drainage r..:

Holmström, Ulrika ; Tsitsopoulos, Parmenion P. ; Flygt, Hjalmar..
Spinal Cord. 56 (2018) 9 - p. 873-882 , 2018

Link: https://doi.org/10.1038/..

8

The impact of Covid-19 in patients with chronic myeloid leu..:

Dahlen, Torsten ; Flygt, Hjalmar ; Lubking, Anna...
Leukemia, 0887-6924, 2023. , 2023

Link: http://urn.kb.se/resolve..

9

The impact of Covid-19 in patients with chronic myeloid leu..:

Dahlén, Torsten ; Flygt, Hjalmar ; Lübking, Anna...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10088575/. , 2023

Link: http://www.ncbi.nlm.nih...

10

The impact of Covid-19 in patients with chronic myeloid leu..:

Dahlén, Torsten ; Flygt, Hjalmar ; Lübking, Anna...
Leukemia, 0887-6924, 2023, 37, s. 1156-1159. , 2023

Link: http://urn.kb.se/resolve..

11

Adverse outcomes in chronic myeloid leukemia patients treat..:

Dahlén, Torsten ; Edgren, Gustaf ; Ljungman, Per...
American Journal of Hematology, 0361-8609, 2022, 97:4, s. 421-430. , 2022

Link: http://urn.kb.se/resolve..

12

Adverse outcomes in chronic myeloid leukemia patients treat..:

Dahlén, Torsten ; Edgren, Gustaf ; Ljungman, Per...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9306877/. , 2022

Link: http://www.ncbi.nlm.nih...

13

Long-term tolerability and efficacy after initial PegIFN-al..:

Flygt, Hjalmar ; Söderlund, Stina ; Stentoft, Jesper...
10.1111/ejh.13699. , 2022

Link: http://hdl.handle.net/10..

14

Adverse outcomes in chronic myeloid leukemia patients treat..:

Dahlén, Torsten ; Edgren, Gustaf ; Ljungman, Per...
American Journal of Hematology, 0361-8609, 2022, 97:4, s. 421-430. , 2022

Link: http://urn.kb.se/resolve..

15

Adverse outcomes in chronic myeloid leukemia patients treat..:

Dahlen, Torsten ; Edgren, Gustaf ; Ljungman, Per...
American Journal of Hematology, 0361-8609, 2022, 97:4, s. 421-430. , 2022

Link: http://urn.kb.se/resolve..